182 related articles for article (PubMed ID: 3011419)
1. Regulation of transferrin receptor expression at the cell surface by insulin-like growth factors, epidermal growth factor and platelet-derived growth factor.
Davis RJ; Czech MP
EMBO J; 1986 Apr; 5(4):653-8. PubMed ID: 3011419
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I and epidermal growth factor regulate the expression of transferrin receptors at the cell surface by distinct mechanisms.
Davis RJ; Faucher M; Racaniello LK; Carruthers A; Czech MP
J Biol Chem; 1987 Sep; 262(27):13126-34. PubMed ID: 3498714
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of epidermal growth factor binding to Swiss 3T3 cells by human platelet release-products.
Brown KD; Blakeley DM; MacDonald M
Biosci Rep; 1983 Jul; 3(7):659-66. PubMed ID: 6313091
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic agents induce redistribution of transferrin receptors from internal pools to the cell surface.
Ward DM; Kaplan J
Biochem J; 1986 Sep; 238(3):721-8. PubMed ID: 3541916
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor rapidly induces a redistribution of transferrin receptor pools in human fibroblasts.
Wiley HS; Kaplan J
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7456-60. PubMed ID: 6095297
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells.
Collins MK; Sinnett-Smith JW; Rozengurt E
J Biol Chem; 1983 Oct; 258(19):11689-93. PubMed ID: 6311820
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.
Bowen-Pope DF; Dicorleto PE; Ross R
J Cell Biol; 1983 Mar; 96(3):679-83. PubMed ID: 6300138
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblasts.
Tamm I; Kikuchi T
J Cell Physiol; 1990 Jun; 143(3):494-500. PubMed ID: 2193035
[TBL] [Abstract][Full Text] [Related]
9. Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells.
Pfeifle B; Boeder H; Ditschuneit H
Endocrinology; 1987 Jun; 120(6):2251-8. PubMed ID: 3032582
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells.
Herman B; Pledger WJ
J Cell Biol; 1985 Apr; 100(4):1031-40. PubMed ID: 3920222
[TBL] [Abstract][Full Text] [Related]
11. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II increases cytoplasmic free calcium in competent Balb/c 3T3 cells treated with epidermal growth factor.
Nishimoto I; Ohkuni Y; Ogata E; Kojima I
Biochem Biophys Res Commun; 1987 Jan; 142(1):275-86. PubMed ID: 3545205
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the kinetics of cycling of the transferrin receptor in the presence or absence of bound diferric transferrin.
Gironès N; Davis RJ
Biochem J; 1989 Nov; 264(1):35-46. PubMed ID: 2604716
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
Mioh H; Chen JK
J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
[TBL] [Abstract][Full Text] [Related]
15. Transmodulation of epidermal growth factor binding by platelet-derived growth factor and 12-O-tetradecanoylphorbol-13-acetate is not sodium-dependent in Balb/c/3T3 cells.
Olson JE; Pledger WJ
J Biol Chem; 1990 Feb; 265(4):1847-51. PubMed ID: 2298725
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I and insulin rapidly increase casein kinase II activity in BALB/c 3T3 fibroblasts.
Klarlund JK; Czech MP
J Biol Chem; 1988 Nov; 263(31):15872-5. PubMed ID: 3053682
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis.
Wharton W; Leof E; Pledger WJ; O'Keefe EJ
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5567-71. PubMed ID: 6291052
[TBL] [Abstract][Full Text] [Related]
18. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane.
Davis RJ; Corvera S; Czech MP
J Biol Chem; 1986 Jul; 261(19):8708-11. PubMed ID: 3013860
[TBL] [Abstract][Full Text] [Related]
19. Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.
Caraglia M; Tagliaferri P; Correale P; Genua G; Pinto A; Del Vecchio S; Esposito G; Bianco AR
Cancer Immunol Immunother; 1993 Aug; 37(3):150-6. PubMed ID: 8392910
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor modulates epidermal growth factor receptors by a mechanism distinct from that of phorbol esters.
Olashaw NE; O'Keefe EJ; Pledger WJ
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3834-8. PubMed ID: 3012534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
